Find-Speaker.com




2nd Priority Review Voucher Summit (description)

""

Category:Medical
Address:101 Harborside Drive Boston, Massachusetts, United States of America 02128
Phone:917-258-5158
Event dates:10/26/2017 - 10/27/2017 (This event has already taken place)
Event web site:http://go.evvnt.com/144194-0
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 2nd Priority Review Voucher Summit

Speakers/Presenters:

Topics to be Covered:

  • Science, Health & Medicine, Pharmaceuticals
Contact:esternberg@exlevents.com
Organizer phone:917-258-5158
Offering type:Data not provided
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:ExL Events
Est. # of exhibitors:
Currency:US Dollars
Language:English
CE Credits:
Organizer URL

Description:

Understand the regulatory landscape, valuation approaches and how to successfully develop a drug to secure a priority review voucher. ExL Events' 2nd Priority Review Voucher Summit will take place October 26-27, 2017 at the Hyatt Regency Boston Harbor in Boston, MA. This conference is the ONLY two-day event dedicated to the FDA incentive program that features in-depth industry knowledge on the Neglected Tropical Disease, Rare Pediatric Disease and Medical Countermeasures priority review voucher programs and their respective eligibility requirements. Attendees will have the opportunity to hear updates on the regulatory and legislative landscape, discuss different valuation models utilized by various stakeholders, and evaluate the role of PRV programs as an active driver for innovation in R&D. Participating Companies From 2016 Include: Adena Partners Management, LLC, Anacor Pharmaceuticals, Bill & Melinda Gates Foundation, Biotechnology Innovation Organization (BIO), Clarus, Drugs for Neglected Diseases (DNDi), Duke University, FDA, Global Alliance for TB Drug Development, Global Health Investment Fund, Janssen, KaloBios, Kids v Cancer, Knight Therapeutics Inc., Medicines Development for Global Health, Medicines for Malaria Venture (MMV), National Organization for Rare Disorders (NORD), Novartis, PATH, Pfizer, Sanofi, and UCB.

Schedule:

Time: 8:00 am to 5:00 pm

Registration Fee Details:

Conference Only - Early Bird - Register by 9/15/2017: USD 1895
Conference Only - Standard - Register after 9/15/2017: USD 2095

Other items that tuition includes:

Travel and hotel arrangements:

 
 
Contact Person:Emily Sternberg
Contact Emailesternberg@exlevents.com
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Organizer Phone917-258-5158
Structural makeupData not provided
Host Sponsor; Other SponsorsExL Events
Event Site/VenueHyatt Regency Boston Harbor
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Range:
Number in attendance of:
Range:
Target BoundariesLocal
Is Registration contact information the same as Organizer Contact above?Yes
Web Page http://go.evvnt.com/144194-2
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA
Additional notes:Booking: https://go.evvnt.com/144194-1

Sign In/Sign Out
About Us
FAQ
Contact Us